14(Z)-tricosenoic acid | 105305-00-8

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: 14(Z)-tricosenoic acid
• 英文别名: 14Z-tricosenoic acid；(Z)-tricos-14-enoic acid
• CAS: 105305-00-8
• 化学式: C₂₃H₄₄O₂
• 分子量: 352.601
• InChiKey: BRCMIDDAOIVEAZ-KTKRTIGZSA-N

物化性质

• 沸点：
  466.4±14.0 °C(Predicted)
• 密度：
  0.889±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  9.2
• 重原子数：
  25
• 可旋转键数：
  20
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.87
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  甲醇 、 14(Z)-tricosenoic acid 生成 Methyl-cis-14-tricosenoat
  参考文献：
  名称：

  TVRZICKA, EVA;REZANKA, TOMAS;KRIJT, JAN;JANOUSEK, VACLAV, J. CHROMATOGR. BIOMED. APPL., 431,(1988) N 2, C. 231-238

  摘要：

  DOI：

文献信息

• Cobalt-Catalyzed Decarboxylative Methylation and Ethylation of Aliphatic N-(Acyloxy)phthalimides with Organoaluminum Reagents
  作者：Rui Shang、Yao Fu、Ze-Zhong Wang、Guang-Zu Wang、Bin Zhao

  DOI：10.1055/s-0040-1707946

  日期：2020.7

  A cobalt-catalyzed decarboxylative methylation of aliphatic redox-active esters [N-(acyloxy)phthalimides; RAEs] with trimethylaluminum under mild conditions was developed, providing a method for transforming a carboxylate group into a methyl group without redox fluctuation. Primary and secondary RAEs were both amenable substrates, whereas a tertiary RAE delivered an elimination product. Triethylaluminum

  脂肪族氧化还原活性酯 [N-（酰氧基）邻苯二甲酰亚胺；RAEs] 与三甲基铝在温和条件下的开发，提供了一种将羧酸盐基团转化为甲基基团而没有氧化还原波动的方法。一级和二级 RAE 都是适合的底物，而三级 RAE 提供消除产物。三乙基铝也用于提供脱羧乙基化产物。
• Assays for screening activity of modulators of members of the hydroxy steroid (17-beta) dehydrogenase (HSD17B) family
  申请人：Regeneron Pharmaceuticals, Inc.

  公开号：US11479802B2

  公开（公告）日：2022-10-25

  Screening methods as well as kits for identifying modulators of hydroxysteroid (17-beta) dehydrogenase (HSD17B) family member proteins, such as HSD17B13, are provided. The methods comprise screening molecules for their capacity to modulate the HSD17B family member protein, including inhibiting the HSD17B family member protein, as measured by substrate depletion, product concentration from the HSD17B family member protein substrate conversion or NADH concentration, levels of labeled substrate, luciferin light emission, or combinations thereof. Inhibitors of HSD17B family member proteins identified through the screening methods may be used to treat liver diseases, disorders, or conditions in which the HSD17B family member protein plays a role.

  本发明提供了用于鉴定羟基类固醇（17-beta）脱氢酶（HSD17B）家族成员蛋白（如 HSD17B13）调节剂的筛选方法和试剂盒。这些方法包括筛选分子，以确定其调节 HSD17B 家族成员蛋白的能力，包括抑制 HSD17B 家族成员蛋白的能力，通过底物耗竭、HSD17B 家族成员蛋白底物转化产物浓度或 NADH 浓度、标记底物水平、荧光素发光或其组合来测量。通过筛选方法鉴定的 HSD17B 家族成员蛋白的抑制剂可用于治疗 HSD17B 家族成员蛋白起作用的肝脏疾病、失调或病症。
• TVRZICKA, EVA;REZANKA, TOMAS;KRIJT, JAN;JANOUSEK, VACLAV, J. CHROMATOGR. BIOMED. APPL., 431,(1988) N 2, C. 231-238
  作者：TVRZICKA, EVA、REZANKA, TOMAS、KRIJT, JAN、JANOUSEK, VACLAV

  DOI：——

  日期：——
• ASSAYS FOR SCREENING ACTIVITY OF MODULATORS OF MEMBERS OF THE HYDROXYSTEROID (17-BETA) DEHYDROGENASE (HSD17B) FAMILY
  申请人：Regeneron Pharmaceuticals, Inc.

  公开号：EP3610029A1

  公开（公告）日：2020-02-19
• Assays For Screening Activity Of Modulators Of Members Of The Hydroxysteroid (17-Beta) Dehydrogenase (HSD17B) Family
  申请人：Regeneron Pharmaceuticals, Inc.

  公开号：US20180291422A1

  公开（公告）日：2018-10-11

  Screening methods as well as kits for identifying modulators of hydroxysteroid (17-beta) dehydrogenase (HSD17B) family member proteins, such as HSD17B13, are provided. The methods comprise screening molecules for their capacity to modulate the HSD17B family member protein, including inhibiting the HSD17B family member protein, as measured by substrate depletion, product concentration from the HSD17B family member protein substrate conversion or NADH concentration, levels of labeled substrate, luciferin light emission, or combinations thereof. Inhibitors of HSD17B family member proteins identified through the screening methods may be used to treat liver diseases, disorders, or conditions in which the HSD17B family member protein plays a role.